Biotech CEO blasts Turing over 5000% price hike
September 23, 2015 at 10:56 AM EDT
John Maraganore of Alnylam Pharmaceuticals tells CNBC his industry focuses on innovation, not pushing prices on decades-old drugs higher to make a profit.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.